Get started
Author

Ethan Mah

Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
2023 · Amish Gaur, Luc Rivet, et al. · Ageing Research Reviews · 35
Angiogenic response of rat hippocampal vasculature to focused ultrasound-mediated increases in blood-brain barrier permeability
2018 · Dallan McMahon, Ethan Mah, et al. · Scientific Reports · 32
PDF
Neuropsychiatric symptoms and their relationship with white matter hyperintensities in mild vascular cognitive impairment, mild cognitive impairment, Alzheimer's disease and mixed dementia – a COMPASS-ND study
2023 · Shankar Tumati, Elizabeth Boyd, et al. · American Journal of Geriatric Psychiatry · 4
MRS demonstrates elevated brain glutathione in vascular mild cognitive impairment compared to cognitively normal coronary artery disease controls
2025 · Jinghan Jenny Chen, Yejin Kang, et al. · Alzheimer s & Dementia · 3
PDF
Efficacy and safety of N‐acetylcysteine in patients with vascular mild cognitive impairment (vMCI): Memory and antioxidant in vMCI Exercise Intervention Trial (MOVE‐IT)
2025 · Yejin Kang, Nathan Herrmann, et al. · Alzheimer s & Dementia · 2
PDF
Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)
2023 · Krista L. Lanctôt, Clara Chen, et al. · International Psychogeriatrics · 2
PDF
White matter hyperintensities moderate neuropsychiatric response to N-acetylcysteine and exercise therapy in vascular mild cognitive impairment
2026 · Ethan Mah, Damien Gallagher, et al. · Journal of Alzheimer s Disease
Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial
2026 · Damien Gallagher, Yejin Kang, et al. · Alzheimer s Research & Therapy
Frontal white matter hyperintensity burden predicts cognitive response to N-acetylcysteine and exercise in vascular mild cognitive impairment
2026 · Ethan Mah, Damien Gallagher, et al. · Neurobiology of Aging
Antioxidant N ‐acetylcysteine as an intervention for neuropsychiatric symptoms in individuals with vascular mild cognitive impairment
2025 · Alan (Jing Chiuan) Peng, Yejin Kang, et al. · Alzheimer s & Dementia
PDF
Evaluating the Predictive Value of Frontal White Matter Hyperintensity Burden on Cognitive Response to NAC and Exercise Therapy in Vascular Mild Cognitive Impairment: Findings from the MOVE‐IT Trial
2025 · Ethan Mah, Damien Gallagher, et al. · Alzheimer s & Dementia
PDF
Frontal White Matter Hyperintensity Burden Predicts Cognitive Response to NAC and Exercise in Vascular Mild Cognitive Impairment
2025 · Krista Lanctot, Ethan Mah, et al. · SSRN Electronic Journal
Brain glutathione in vascular mild cognitive impairment and cognitive correlates
2024 · Jinghan Jenny Chen, Nathan Herrmann, et al. · Alzheimer s & Dementia
PDF
Lipid peroxidation in patients with vascular mild cognitive impairment from a memory and antioxidants in vascular impairment trial (MOVE‐IT)
2024 · Yejin Kang, Jinghan Jenny Chen, et al. · Alzheimer s & Dementia
PDF
Fluid Biomarkers of Neurodegeneration in Mild Cognitive Impairment: A Meta‐Analysis
2023 · Amish Gaur, Luc Rivet, et al. · Alzheimer s & Dementia
PDF
A meta-analysis of neurofilament light chain as a biomarker for mild cognitive impairment
2023 · Amish Gaur, Luc Rivet, et al. · American Journal of Geriatric Psychiatry
Cost Consequence Analysis of ADMET 2
2023 · Ethan Mah, Krista Lanctôt, et al. · American Journal of Geriatric Psychiatry
Works count: 17
Citation count: 78
H-index: 3
I10-index: 2
Year
Topic
Type